Segment Information by Division

For the Period January 1 to December 31

2015

 Download XLS

 

 

 

€ million

 

Silicones

 

Polymers

 

Bio­solutions

 

Polysilicon

 

Siltronic

 

Other

 

Conso­lidation

 

Group

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1

Intangible assets; property, plant and equipment; investment property

 

The segment information by division is an integral part of the Notes to the Consolidated Financial Statements. For explanations of the key indicators, see Note 22.

External sales

 

1,942.8

 

1,162.5

 

197.1

 

978.9

 

923.8

 

91.1

 

 

5,296.2

Internal sales

 

0.5

 

23.0

 

 

84.7

 

7.5

 

106.4

 

-222.1

 

Total sales

 

1,943.3

 

1,185.5

 

197.1

 

1,063.6

 

931.3

 

197.5

 

-222.1

 

5,296.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT

 

194.5

 

184.4

 

21.0

 

162.6

 

4.5

 

-94.5

 

0.9

 

473.4

Depreciation and impairment losses / reversals

 

81.7

 

37.8

 

11.2

 

239.8

 

119.5

 

85.6

 

-0.2

 

575.4

EBITDA

 

276.2

 

222.2

 

32.2

 

402.4

 

124.0

 

-8.9

 

0.7

 

1,048.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT includes:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Result from investments in joint ventures and associates

 

3.3

 

 

 

 

 

 

 

3.3

Asset additions1

 

82.0

 

47.4

 

6.2

 

581.8

 

75.1

 

41.5

 

 

834.0

Asset additions

 

82.0

 

47.4

 

6.2

 

581.8

 

75.1

 

41.5

 

 

834.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets (Dec. 31)

 

1,309.3

 

589.9

 

149.3

 

3,132.0

 

1,016.1

 

1,096.3

 

-28.5

 

7,264.4

Liabilities (Dec. 31)

 

749.0

 

281.1

 

67.0

 

1,392.0

 

543.5

 

1,451.5

 

-14.8

 

4,469.3

Net assets (Dec. 31)

 

560.3

 

308.8

 

82.3

 

1,740.0

 

472.6

 

-355.2

 

-13.7

 

2,795.1

Investments in joint ventures and associates included in net assets (Dec. 31)

 

21.2

 

 

 

 

 

 

 

21.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development expenses

 

35.8

 

14.8

 

6.1

 

15.3

 

64.3

 

42.8

 

-3.8

 

175.3

Employees (Dec. 31)

 

4,353

 

1,461

 

491

 

2,373

 

3,894

 

4,400

 

 

16,972

Employees (average)

 

4,348

 

1,442

 

491

 

2,278

 

4,004

 

4,374

 

 

16,937

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2014

 Download XLS

 

 

 

€ million

 

Silicones

 

Polymers

 

Bio­solutions

 

Polysilicon

 

Siltronic

 

Other

 

Conso­lidation

 

Group

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1

Intangible assets; property, plant and equipment; investment property

 

The segment information by division is an integral part of the Notes to the Consolidated Financial Statements. For explanations of the key indicators, see Note 22.

External sales

 

1,733.3

 

1,040.5

 

176.2

 

949.5

 

848.0

 

78.9

 

 

4,826.4

Internal sales

 

0.3

 

23.9

 

 

99.6

 

5.4

 

87.0

 

-216.2

 

Total sales

 

1,733.6

 

1,064.4

 

176.2

 

1,049.1

 

853.4

 

165.9

 

-216.2

 

4,826.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT

 

128.9

 

118.7

 

13.6

 

305.3

 

-43.5

 

-75.4

 

-4.3

 

443.3

Depreciation and impairment losses / reversals

 

80.9

 

30.8

 

10.0

 

231.7

 

157.5

 

88.1

 

 

599.0

EBITDA

 

209.8

 

149.5

 

23.6

 

537.0

 

114.0

 

12.7

 

-4.3

 

1,042.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT includes:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from investments in joint ventures and associates

 

2.9

 

 

 

 

 

 

 

2.9

Impairment losses

 

 

 

 

 

-9.5

 

 

 

-9.5

Asset additions1

 

88.5

 

56.3

 

8.4

 

334.5

 

40.7

 

43.8

 

 

572.2

Asset additions

 

88.5

 

56.3

 

8.4

 

334.5

 

40.7

 

43.8

 

 

572.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets (Dec. 31)

 

1,255.1

 

546.4

 

145.7

 

2,620.7

 

1,044.1

 

1,535.1

 

-199.9

 

6,947.2

Liabilities (Dec. 31)

 

762.1

 

297.9

 

75.2

 

1,623.9

 

758.8

 

1,668.0

 

-185.2

 

5,000.7

Net assets (Dec. 31)

 

493.0

 

248.5

 

70.5

 

996.8

 

285.3

 

-132.9

 

-14.7

 

1,946.5

Investments in joint ventures and associates included in net assets (Dec. 31)

 

20.5

 

 

 

 

 

 

 

20.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development expenses

 

39.5

 

13.2

 

6.7

 

18.7

 

64.6

 

40.4

 

 

183.1

Employees (Dec. 31)

 

4,240

 

1,408

 

484

 

2,093

 

4,165

 

4,313

 

 

16,703

Employees (average)

 

4,201

 

1,400

 

476

 

2,083

 

4,263

 

4,321

 

 

16,744